In conclusion, the albumin-NLR inflammation scoring method outperformed both the SIS and mGPS in predicting survival in CRC patients undergoing resection, indicating that albumin-NLR is a useful inflammatory marker. The gene discussed is ALB; the disease is colorectal carcinoma.